Advertisement
LUNG vs UTMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUNG is a Hold and UTMD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LUNG’s FA Score shows that 1 FA rating(s) are green whileUTMD’s FA Score has 2 green FA rating(s).
- LUNG’s FA Score: 1 green, 4 red.
- UTMD’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LUNG’s TA Score shows that 6 TA indicator(s) are bullish while UTMD’s TA Score has 4 bullish TA indicator(s).
- LUNG’s TA Score: 6 bullish, 4 bearish.
- UTMD’s TA Score: 4 bullish, 4 bearish.
Price Growth
LUNG (@Medical/Nursing Services) experienced а -6.61% price change this week, while UTMD (@Pharmaceuticals: Other) price change was +0.77% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +6.51%, and the average quarterly price growth was -7.37%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.08%. For the same industry, the average monthly price growth was +10.50%, and the average quarterly price growth was +5.94%.
Reported Earning Dates
LUNG is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical/Nursing Services (-0.94% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-0.08% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| LUNG | UTMD | LUNG / UTMD | |
| Capitalization | 97.1M | 228M | 43% |
| EBITDA | -48.22M | 13.9M | -347% |
| Gain YTD | 2.262 | 29.075 | 8% |
| P/E Ratio | N/A | 21.85 | - |
| Revenue | 88.5M | 37.5M | 236% |
| Total Cash | 61.6M | 87.4M | 70% |
| Total Debt | 56.3M | 210K | 26,810% |
LUNG | UTMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 27 Undervalued | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 73 | |
PRICE GROWTH RATING 1..100 | 35 | 47 | |
P/E GROWTH RATING 1..100 | 100 | 17 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UTMD's Valuation (14) in the Medical Specialties industry is in the same range as LUNG (27) in the null industry. This means that UTMD’s stock grew similarly to LUNG’s over the last 12 months.
UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as LUNG (100) in the null industry. This means that UTMD’s stock grew similarly to LUNG’s over the last 12 months.
UTMD's SMR Rating (73) in the Medical Specialties industry is in the same range as LUNG (99) in the null industry. This means that UTMD’s stock grew similarly to LUNG’s over the last 12 months.
LUNG's Price Growth Rating (35) in the null industry is in the same range as UTMD (47) in the Medical Specialties industry. This means that LUNG’s stock grew similarly to UTMD’s over the last 12 months.
UTMD's P/E Growth Rating (17) in the Medical Specialties industry is significantly better than the same rating for LUNG (100) in the null industry. This means that UTMD’s stock grew significantly faster than LUNG’s over the last 12 months.
| LUNG | UTMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 87% | N/A |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 58% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 68% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 54% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 61% |
| Advances ODDS (%) | 4 days ago 80% | 4 days ago 59% |
| Declines ODDS (%) | 2 days ago 83% | 9 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 62% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 54% |
Advertisement
LUNG and
Correlation & Price change
A.I.dvisor indicates that over the last year, LUNG has been loosely correlated with SRTS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if LUNG jumps, then SRTS could also see price increases.
| Ticker / NAME | Correlation To LUNG | 1D Price Change % | ||
|---|---|---|---|---|
| LUNG | 100% | -1.74% | ||
| SRTS - LUNG | 57% Loosely correlated | +3.41% | ||
| BAX - LUNG | 53% Loosely correlated | -0.27% | ||
| ALGN - LUNG | 52% Loosely correlated | +2.27% | ||
| UTMD - LUNG | 32% Poorly correlated | +0.18% | ||
| NNOX - LUNG | 31% Poorly correlated | -2.84% | ||
More | ||||
UTMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To UTMD | 1D Price Change % | ||
|---|---|---|---|---|
| UTMD | 100% | +0.18% | ||
| CERS - UTMD | 50% Loosely correlated | +0.72% | ||
| TMCI - UTMD | 47% Loosely correlated | -2.69% | ||
| INMD - UTMD | 47% Loosely correlated | +0.94% | ||
| ITGR - UTMD | 44% Loosely correlated | -0.01% | ||
| IART - UTMD | 43% Loosely correlated | +0.90% | ||
More | ||||